$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Dry direct compression compositions for controlled release dosage forms 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-009/20
  • A61K-009/22
  • A61K-009/26
출원번호 US-0124887 (1987-11-24)
발명자 / 주소
  • Jang Choong-Gook (12D Jules La. New Brunswick NJ 08901)
인용정보 피인용 횟수 : 69  인용 특허 : 3

초록

The selection of: a hydrophobic carbohydrate polymer, e.g. ethyl cellulose; and, generally at least one digestive-difficulty soluble component, i.e. a wax, e.g. carnauba wax, fatty acid material or neutral lipid provides upon dry direct compression a controlled and continuous release matrix for tabl

대표청구항

A dry, direct compressed product containing controlled release dosage forms of therapeutically active particulate agents produced without heat or solvents by the steps comprising: (a) dry blending blend particles, all of which have particle sizes smaller than 20 mesh, consisting essentially of from

이 특허에 인용된 특허 (3)

  1. Sheth Prabhakar R. (Pearl River NY) Tossounian Jacques L. (Pine Brook NJ), Novel sustained release tablet formulations.
  2. Leslie Stewart Thomas (Aberdeen SC), Slow release pharmaceutical compositions.
  3. Rotman Avner (6 Alkalai Street Rehovot ILX), Sustained release tablets made from microcapsules.

이 특허를 인용한 특허 (69)

  1. Sowden, Harry S.; Li, Shun Por, Apparatus for manufacturing dosage forms.
  2. Li, Shun-Por; Lee, Der-Yang; Bunick, Frank J.; Chen, Jen Chi; Sowden, Harry S., Burst-release polymer composition and dosage forms comprising the same.
  3. Geyer, Robert P.; Tuliani, Vinod V., Chewable drug-delivery composition.
  4. Lee, Der-Yang; Sowden, Harry S.; Thomas, Martin, Composite dosage forms having an inlaid portion.
  5. Gutsmann, Volker; Bocker, Thomas; Nentwig, Guenther; Sonneck, Rainer; Hack, Beate; Duff, Daniel Gordon, Composition comprising insecticide-wax particles.
  6. Mulye, Nirmal, Control release formulation containing a hydrophobic material as the sustained release agent.
  7. Mulye,Nirmal, Control release formulation containing a hydrophobic material as the sustained release agent.
  8. Radwanski, Fred R.; Clark, James W.; Anderson, Ralph L., Controlled release anti-microbial hard surface wiper.
  9. Upadhyay, Ajay Hasmukhlal; Camarco, Wayne, Directly compressible acetaminophen compositions.
  10. Hamm, Mark A; Barbato, Louis J; Crowley, Robert J; Naimark, Wendy; Patel, Hatal, Energetically-controlled delivery of biologically active material from an implanted medical device.
  11. Hamm,Mark A; Barbato,Louis J; Crowley,Robert J; Naimark,Wendy; Patel,Hatal, Energetically-controlled delivery of biologically active material from an implanted medical device.
  12. Oshlack Benjamin ; Chasin Mark ; Huang Hua-Pin, Extruded multi-particulates.
  13. Oshlack Benjamin ; Chasin Mark ; Huang Hua-Pin, Extruded orally administrable opioid formulations.
  14. Gregory P. Kushla ; Jin-Wang Lai ; Gerald P. Polli, Ibuprofen and narcotic analgesic compositions.
  15. Kushla, Gregory P.; Lai, Jin-Wang; Polli, Gerald P., Ibuprofen and narcotic analgesic compositions.
  16. Luber,Joseph; Bunick,Frank J., Immediate release tablet.
  17. Wang Paul Yao-Cheung,CAX ITX M1T 2H5, Implant preparations containing bioactive macromolecule for sustained delivery.
  18. Moskowitz, Michael A.; Liao, James K.; Ron, Eyal S.; Omstead, Mary Nallin, Increasing cerebral bioavailability of drugs.
  19. Cefali, Eugenio A.; Bova, David J., Intermediate release nicotinic acid compositions for treating hyperlipidemia.
  20. Cefali, Eugenio A., Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics.
  21. Schierholz, Jorg, Medical products with sustained pharmacological activity and process for producing them.
  22. Oshlack Benjamin ; Chasin Mark ; Huang Hua-Pin ; Sackler David, Melt-extruded orally administrable opioid formulations.
  23. Oshlack, Benjamin; Chasin, Mark; Huang, Hua-Pin; Sackler, David, Melt-extruded orally administrable opioid formulations.
  24. Benjamin Oshlack ; Hua-Pin Huang ; Mark Chasin, Melt-extrusion multiparticulates.
  25. Oshlack, Benjamin; Chasin, Mark; Huang, Hua-Pin, Melt-extrusion multiparticulates.
  26. Oshlack,Benjamin; Chasin,Mark; Huang,Hua Pin, Melt-extrusion multiparticulates.
  27. Sowden, Harry S.; Plantz, Bernard F.; Li, Shun Por, Method for manufacturing dosage forms.
  28. Rein, Hubert; Steffens, Klaus-Jurgen, Method for producing a water-insoluble amorphous or partially amorphous controlled release matrix.
  29. Sowden, Harry S.; Plantz, Bernard F.; Li, Shun Por, Method of coating a dosage form comprising a first medicant.
  30. Gregory P. Kushla ; Jin-Wang Lai ; Gerald P. Polli, Method of making ibuprofen and narcotic analgesic composition.
  31. Kushla, Gregory P.; Lai, Jin-Wang; Polli, Gerald P., Method of making ibuprofen and narcotic analgesic compositions.
  32. Li, Shun-Por; Sowden, Harry S.; Wynn, David; Lee, Der-Yang; Thomas, Martin, Method of manufacturing modified release dosage forms.
  33. Bova David J., Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night.
  34. Cefali, Eugenio A.; Bova, David J., Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia.
  35. Kranzler, Jay D.; Rao, Srinivas G., Methods of treating fibromyalgia syndrome, chronic fatigue syndrome and pain.
  36. Kranzler, Jay D.; Rao, Srinivas G., Methods of treating fibromyalgia syndrome, chronic fatigue syndrome and pain.
  37. Theus, Jon Scott, Micro- and nano-quantity sleep enhancing nutrient composition and method of enhancing central nervous system protein clearance using same.
  38. Rao, Srinivas G.; Gendreau, Michael; Kranzler, Jay D., Milnacipran for the long-term treatment of fibromyalgia syndrome.
  39. Sowden, Harry S., Modified release dosage form.
  40. Wynn, David; McNally, Gerard P.; Sowden, Harry S., Modified release dosage form.
  41. Li, Shun-Por; Sowden, Harry S; Wynn, David; Lee, Der-Yang; Thomas, Martin, Modified release dosage forms.
  42. Sowden, Harry S.; Wynn, David; Li, Shun-Por; Lee, Der-Yang; Thomas, Martin, Modified release dosage forms.
  43. Venkatesh, Gopi M.; Clevenger, James M., Modified release dosage forms of skeletal muscle relaxants.
  44. Venkatesh, Gopi M.; Clevenger, James M., Modified release dosage forms of skeletal muscle relaxants.
  45. Venkatesh, Gopi; Clevenger, James M., Modified release dosage forms of skeletal muscle relaxants.
  46. Venkatesh, Gopi; Clevenger, James M., Modified release dosage forms of skeletal muscle relaxants.
  47. Venkatesh, Gopi; Clevenger, James M., Modified release dosage forms of skeletal muscle relaxants.
  48. Venkatesh, Gopi; Clevenger, James M., Modified release dosage forms of skeletal muscle relaxants.
  49. Venkatesh, Gopi; Clevenger, James M., Modified release dosage forms of skeletal muscle relaxants.
  50. Venkatesh,Gopi; Clevenger,James M., Modified release dosage forms of skeletal muscle relaxants.
  51. Oberegger, Werner; Eradiri, Okponanabofa; Zhou, Fang; Maes, Paul, Modified release tablet of bupropion hydrochloride.
  52. Bova David J., Nicotinic acid compositions for treating hyperlipidemia and related methods therefor.
  53. Bova, David J, Nicotinic acid compositions for treating hyperlipidemia and related methods therefor.
  54. Moneymaker, Ricky Dean; Theus, Jon Scott; Klesman, Larry Scott, Nutrient composition(s) and system(s) for individualized, responsive dosing regimens.
  55. Leslie Stewart Thomas,GBX ; Knott Trevor John,GBX ; Mohammad Hasssan,GBX ; Prater Derek Allan,GBX, Pharmaceutical composition containing a fusible carrier and method for producing the same.
  56. van Winkelhoff Arie J. (Houten NLX) Winkel Edwin G. (Amsterdam NLX) Goene Ronald J. (Hoogwoud NY NLX) Christersson Lars A. (Amherst NY) Zambon Joseph J. (Williamsville NY) Genco Robert J. (Buffalo NY, Pharmaceutical composition for the treatment of periodontitis.
  57. Schock Herbert (Cincinnati OH) Long David F. (Loveland OH) Nadler William R. (Cincinnati OH), Pharmaceutical compositions for piperidinoalkanol-ibuprofen combination.
  58. Moneymaker, Ricky Dean; Klesman, Larry Scott; Theus, Jon Scott, Pharmanutrient composition(s) and system(s) for individualized, responsive dosing regimens.
  59. Tajima Masahiro (Yokohama JPX) Yoshimoto Takashi (Sendai JPX) Fukushima Shoji (Yokohama JPX) Kaminuma Toshihiko (Yokohama JPX) Ehama Ritsuko (Tokyo JPX) Baba Takaaki (Yokohama JPX) Watabe Kazuo (Yoko, Physiologically active substance-prolonged releasing-type pharmaceutical preparation.
  60. Ishimaru Sueaki (Menuma JPX) Ouchi Kiyohisa (Menuma JPX) Takeuchi Kimito (Menuma JPX) Yamada Masaki (Menuma JPX), Readily absorbable drug formulation of NB-818.
  61. Emanuel, Noam; Neuman, Moshe; Barak, Shlomo, Sustained-release drug carrier composition.
  62. Emanuel, Noam; Neuman, Moshe; Barak, Shlomo, Sustained-release drug carrier composition.
  63. Emanuel, Noam; Rosenfeld, Yosef, Sustained-release nucleic acid matrix compositions.
  64. Emanuel, Noam; Rosenfeld, Yosef, Sustained-release nucleic acid matrix compositions.
  65. Sowden,Harry S., Systems, methods and apparatuses for manufacturing dosage forms.
  66. Sowden,Harry S., Systems, methods and apparatuses for manufacturing dosage forms.
  67. Sowden,Harry S., Systems, methods and apparatuses for manufacturing dosage forms.
  68. Anderson, Ralph L.; Clark, James W.; Radwanski, Fred R., Use-dependent indicator system for absorbent articles.
  69. Anderson, Ralph L.; Radwanski, Fred R.; Clark, James W., Wiper containing a controlled-release anti-microbial agent.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로